Fig. 2: Site of 156 triple-negative breast carcinoma samples tested with PD-L1 (SP142) immunohistochemistry by PD-L1 result.

There was a significant association with positive PD-L1 status and primary tumor samples, compared with recurrent and metastatic tumor samples (p = 0.002, by χ² test).